112 related articles for article (PubMed ID: 6353339)
1. [Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice].
Grosset J; Truffot-Pernot C; Lecoeur H; Guelpa-Lauras CC
Pathol Biol (Paris); 1983 May; 31(5):446-50. PubMed ID: 6353339
[TBL] [Abstract][Full Text] [Related]
2. [Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
Truffot-Pernot C; Grosset J; Bismuth R; Lecoeur H
Rev Fr Mal Respir; 1983; 11(6):875-82. PubMed ID: 6669798
[TBL] [Abstract][Full Text] [Related]
3. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
Grosset J; Truffot C; Fermanian J; Lecoeur H
Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
[TBL] [Abstract][Full Text] [Related]
7. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
Lecoeur HF; Lagrange PH; Truffot-Pernot C; Gheorghiu M; Grosset J
Clin Exp Immunol; 1989 Jun; 76(3):458-62. PubMed ID: 2502336
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the effects of the initial phase of tuberculosis chemotherapy.
Tousek J; Zítková L; Trnka L; Staflová S; Papezová E; Drápela J
Czech Med; 1980; 3(2):114-22. PubMed ID: 7418568
[TBL] [Abstract][Full Text] [Related]
9. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis.
Dhillon J; Dickinson JM; Guy JA; Ng TK; Mitchison DA
Tuber Lung Dis; 1992 Apr; 73(2):116-23. PubMed ID: 1643297
[TBL] [Abstract][Full Text] [Related]
10. Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.
Grosset J; Lounis N; Truffot-Pernot C; O'Brien RJ; Raviglione MC; Ji B
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1436-40. PubMed ID: 9603120
[TBL] [Abstract][Full Text] [Related]
11. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
Lecoeur HF; Truffot-Pernot C; Grosset JH
Am Rev Respir Dis; 1989 Nov; 140(5):1189-93. PubMed ID: 2817579
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
13. Induction of rifampicin metabolism during treatment of tuberculous patients with daily and fully intermittent regimens containing the drug.
Immanuel C; Jayasankar K; Narayana AS; Santha T; Sundaram V; Sarma GR
Indian J Chest Dis Allied Sci; 1989; 31(4):251-7. PubMed ID: 2576931
[TBL] [Abstract][Full Text] [Related]
14. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
16. Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.
Paramasivan CN; Kubendiran G; Herbert D
Indian J Med Res; 1998 Oct; 108():115-9. PubMed ID: 9805839
[TBL] [Abstract][Full Text] [Related]
17. [New aspects of tuberculosis therapy].
Haegi V
Schweiz Med Wochenschr; 1975 Feb; 105(8):245-50. PubMed ID: 1124382
[TBL] [Abstract][Full Text] [Related]
18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
